October 11th 2024
A new AHA statement highlights the benefits of lipoprotein apheresis for familial hypercholesterolemia and urges broader access to the underutilized therapy.
Coronary Heart Disease Risk Among Antipsychotics
November 21st 2008Certain antipsychotics, particularly olanzapine and quetiapine, are associated with an increased risk of coronary heart disease (CHD), whereas others—like perphenazine, risperidone and ziprasidone—lead to a decreased risk of CHD, results of a new study in the Journal of Schizophrenia Research show.
The prognostic role of metabolic syndrome after myocardial infarction
September 24th 2008We evaluated the prognostic role of metabolic syndrome after myocardial infarction and found that metabolic syndrome correlated with an increased risk of cardiovascular events and death. The risk of developing diabetes decreased with weight loss in patients with metabolic syndrome. These results indicate that a more aggressive approach to the treatment of patients with metabolic syndrome, particularly with regard to changes in lifestyle, would be beneficial.
Thoracic and abdominal aorticatherosclerosis
It was not until Virchow identified the cellular contributions to thrombosis that physicians began to visualize arteries as dynamic tissues.